63. Idiopathic thrombocytopenic purpura Clinical trials / Disease details


Clinical trials : 363 Drugs : 212 - (DrugBank : 43) / Drug target genes : 47 - Drug target pathways : 138

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1ChiCTR2000039630
2021-01-012020-11-03Phase II clinical trial of the superiority of montelukastine in combination with TPO-MPL agonists for the treament of primary immune thrombocytopeniaPhase II clinical trial of the superiority of montelukastine in combination with TPO-MPL agonists for the treament of primary immune thrombocytopenia Primary immune thrombocytopeniaexperimental group:Montelukast sodium 10mg/day; rhTPO 15000 units;control group:rhTPO 15000 units;Department of Hematology, Second Medical Center, Chinese PLA General HospitalNULLRecruiting1480Bothexperimental group:51;control group:51;Phase 2China